DNA Data Storage Market (2026-2036)

The growth of this market is mainly driven by the rapid accumulation of archival data that is retained indefinitely but accessed rarely, the power, footprint, and media migration costs of conventional archival storage at exabyte scale, the exceptional density and longevity of DNA as a storage medium, and demand for physically air-gapped storage that cannot be reached over a network. In addition, the declining cost of high-throughput DNA writing, the maturation of enzymatic writing methods designed for data rather than biology, the falling cost and rising throughput of reading, the formation of industry alliances working toward interoperability, and early commercial launches that move the technology from laboratory demonstration toward paid service are further supporting the growth of this market.

The DNA Data Storage Market, also referred to as the molecular data storage market, synthetic DNA storage market, or DNA-based archival storage market, comprises the technologies, media, systems, software, and services used to encode digital information into synthetic DNA sequences, store that DNA, and read it back as data. The market includes DNA writing systems and the reagents and consumables they consume; the physical storage media and preservation formats in which encoded DNA is held, including dried, encapsulated, and cartridge formats; reading systems, which are sequencing platforms configured for data recovery; encoding, error-correction, indexing, random-access, and file-system software; and the managed services through which organizations store data in DNA without operating the technology themselves. The market ecosystem extends from DNA writing and sequencing technology providers, specialist DNA storage companies, storage hardware and semiconductor companies, and standards alliances to hyperscale and enterprise data center operators, national archives, libraries, museums, government and defence organizations, media companies, financial institutions, and research institutions.

DNA is attractive as a storage medium for reasons that are physical rather than commercial. Information encoded in DNA occupies a volume orders of magnitude smaller than the equivalent data on tape or disk, and DNA held in suitable conditions remains readable for decades to centuries without power. These properties address the structural difficulty of archival storage, which is that conventional media must be migrated to new generations every several years, and that migrating exabyte-scale archives consumes capital, labour, and energy indefinitely. A medium that requires no power and no migration changes the economics of very long retention.

The pressure on archival storage is real and growing. According to the LTO Program, total shipped LTO tape capacity increased 57% year over year in the first quarter of 2026, following 160.3 exabytes shipped in 2025 and a record 176.5 exabytes in 2024, with demand attributed to rising capacity requirements, data center power constraints, the need for physically air-gapped cyber resilience, and the retention of artificial intelligence (AI) training datasets. Tape remains the dominant cold storage medium and is growing rather than declining, which demonstrates both the scale of archival demand and the fact that DNA is not displacing tape at present. DNA storage is instead positioned, initially, for retention periods and use cases that tape serves poorly, including multi-decade preservation without migration and storage that is physically unreachable over a network.

The market has begun to move from demonstration to commerce. In March 2026, Biomemory, a DNA data storage company founded in Paris in 2021, acquired the assets of Catalog Technologies of Boston, combining enzymatic DNA block assembly, high-speed writing, and high-throughput reading, and stated its intention to launch its first commercial product in the second half of 2026 as an alternative to conventional storage media, with mass deployment in data center environments as its longer-term objective. In October 2026, Biomemory launched DNA Shield, a synthetic DNA repository service that holds critical digital assets offline and air-gapped without power, with subscriptions starting at EUR 10,000 per month, a claimed retention period of approximately 150 years, and limited pilots running from October 15, 2026 to mid-2027 ahead of general availability. The pricing and scope of this first service are instructive: it is priced for high-value assets rather than bulk capacity, and it is sold as a vaulting service rather than as media or hardware, which reflects the stage the technology has reached.

Cost remains the central constraint. Biomemory introduced its first DNA storage cards in December 2023 at a price of USD 1,000 for up to one kilobyte of data, and raised a USD 18 million Series A round in December 2024 to complete its first-generation storage appliance and accelerate commercialization, indicating both the early stage of the technology and the investment required to industrialize it. Writing DNA at the cost per terabyte required for bulk archival storage requires reductions of several orders of magnitude from current levels, which is why early commercial activity concentrates on small volumes of high-value data where the value of density, longevity, and air-gapping outweighs the cost per byte.

Progress depends on the underlying DNA writing and reading industries, which are developing for reasons unrelated to data storage. In its fiscal third quarter of 2026, ended June 30, 2026, Twist Bioscience Corporation reported record revenue of USD 118.4 million, up 23% year over year, with DNA Synthesis and Protein Solutions revenue of USD 56.6 million, up 39%, reflecting the scale and continuing cost reduction of the high-throughput DNA writing platforms on which DNA data storage depends. High-throughput platforms built for life science research provide the writing capacity that DNA storage requires, and sequencing platforms provide the reading capacity, so DNA storage benefits from cost reduction driven by a far larger market. Enzymatic writing methods, which operate in aqueous conditions and are designed for throughput rather than for producing biologically functional sequences, are of particular interest for data applications.

Software is a larger part of the problem than the physical medium suggests. Encoding schemes must tolerate the error characteristics of writing and reading, which differ from those of electronic media, and must support indexing and random access so that a file can be retrieved without reading an entire archive. Error correction, file systems, and retrieval software therefore determine much of the practical usability of a DNA archive, and the DNA Data Storage Alliance has worked on interoperability so that DNA written by one system can be read by another.

The market includes specialist DNA storage companies such as Biomemory, which acquired the assets of Catalog Technologies, together with DNA writing and sequencing technology providers including Twist Bioscience, Illumina, Oxford Nanopore Technologies, and enzymatic writing companies such as DNA Script and Ansa Biotechnologies, and storage and semiconductor companies including Western Digital, Seagate Technology, and Micron Technology that participate through the DNA Data Storage Alliance and research collaboration. Participants compete and collaborate on write cost and throughput, read cost and speed, error rate, random-access capability, media stability, interoperability, and the credibility of long-term service commitments.

At the same time, the market faces substantial challenges, including a write cost far above that of conventional media, write and read latency measured in hours rather than milliseconds, the absence of mature standards and of a second source for most components, the difficulty of persuading organizations to commit records to a technology with no long operational history, the risk that a provider will not exist for the retention period it promises, and the continuing improvement of tape, which raises the bar DNA must clear. As a result, participants that combine order-of-magnitude write cost reduction, demonstrated retrieval reliability, standards-based interoperability, and credible custodial arrangements are expected to capture the largest share of growth over the forecast period.